Request Demo
Last update 26 Nov 2025
MDX-2003
Last update 26 Nov 2025
Overview
Basic Info
Drug Type Tetraspecific antibody |
Synonyms Therapeutics LASER (OPKO), MDX 2003, MDX2003 |
Target |
Action modulators |
Mechanism CD19 modulators(B-lymphocyte antigen CD19 modulators), CD20 modulators(B-lymphocyte antigen CD20 modulators), CD28 modulators(T-cell-specific surface glycoprotein CD28 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with MDX-2003NCT07249905
A Phase 1/2 Clinical Study Evaluating MDX2003 in Participants With Relapsed, Progressive, or Refractory B-Cell Malignancies
100 Clinical Results associated with MDX-2003
Login to view more data
100 Translational Medicine associated with MDX-2003
Login to view more data
100 Patents (Medical) associated with MDX-2003
Login to view more data
100 Deals associated with MDX-2003
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Follicular Lymphoma | Phase 2 | - | 01 Mar 2026 | |
| High grade B-cell lymphoma | Phase 2 | - | 01 Mar 2026 | |
| Lymphoplasmacytic Lymphoma | Phase 2 | - | 01 Mar 2026 | |
| Mediastinal large B-cell lymphoma | Phase 2 | - | 01 Mar 2026 | |
| Waldenstrom Macroglobulinemia | Phase 2 | - | 01 Mar 2026 | |
| B-Cell Lymphoma | Preclinical | United States | 09 Mar 2023 | |
| Leukemia | Preclinical | United States | 09 Mar 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free